logo
logo

Minaris Advanced Therapies Appoints Dr. Orla Cloak As Chief Executive Officer

Jul 21, 2025•18 days ago

Position

Chief Executive Officer

Company

Minaris Advanced Therapies

Orla Cloak
PhiladelphiaBiotechnologyHealth CareManufacturing

Description

Minaris Advanced Therapies announces the appointment of Dr. Orla Cloak as the new Chief Executive Officer. With over 20 years of leadership experience in the pharma and life sciences sector, Dr Cloak aims to drive the next growth phase of the company.

Company Information

Company

Minaris Advanced Therapies

Location

Philadelphia, Pennsylvania, United States

About

Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 650,000 square feet of infrastructure across the United States, Europe and Asia. We have manufactured and released over 7,500 GMP batches and our global network supports therapy developers through early-stage development, clinical trials and commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, we help bring safe, effective therapies to patients faster and more efficiently.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months